Sodium‑glucose cotransporter 2 inhibitors (SGLT2i): renal implications
Type 2 diabetes mellitus (DM2) is a chronic condition that affects more than 400 million individuals worldwide. In DM2 patients, an appropriate glycemic control slows the onset and delays the progression of all its micro and macrovascular complications. Even though there are several glucose-lowering...
- Autores:
-
Castañeda, Alejandrina M.
Dutra‑Rufato, Amanda
Juarez, Maria J.
Grosembacher, Luis
Gonzalez‑Torres, Henry
Musso, Carlos G.
- Tipo de recurso:
- Fecha de publicación:
- 2020
- Institución:
- Universidad Simón Bolívar
- Repositorio:
- Repositorio Digital USB
- Idioma:
- eng
- OAI Identifier:
- oai:bonga.unisimon.edu.co:20.500.12442/6244
- Acceso en línea:
- https://hdl.handle.net/20.500.12442/6244
https://doi.org/10.1007/s11255-020-02585-w
- Palabra clave:
- SGLT2i
Kidney
Glucosuria
- Rights
- openAccess
- License
- Attribution-NonCommercial-NoDerivatives 4.0 Internacional